Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / SHS
-
Number of holders
-
40
-
Total 13F shares, excl. options
-
20,384,455
-
Shares change
-
+214,708
-
Total reported value, excl. options
-
$137,182,286
-
Value change
-
+$1,373,732
-
Number of buys
-
19
-
Number of sells
-
-21
-
Price
-
$6.73
Significant Holders of AC Immune SA - SHS (ACIU) as of Q2 2020
52 filings reported holding ACIU - AC Immune SA - SHS as of Q2 2020.
AC Immune SA - SHS (ACIU) has 40 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20,384,455 shares
.
Largest 10 shareholders include BVF INC/IL (11,318,758 shares), Temasek Holdings (Private) Ltd (2,614,095 shares), Prosight Management, LP (1,176,801 shares), Artal Group S.A. (984,550 shares), RENAISSANCE TECHNOLOGIES LLC (786,011 shares), ACADIAN ASSET MANAGEMENT LLC (769,052 shares), BlackRock Inc. (755,454 shares), MILLENNIUM MANAGEMENT LLC (517,236 shares), ARROWSTREET CAPITAL, LIMITED PARTNERSHIP (201,319 shares), and WELLS FARGO & COMPANY/MN (180,142 shares).
This table shows the top 40 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.